Six notes:
1. Net sales of $1.9 billion represent a 3.9% increase year-over-year, according to a news release.
2. Highlights of the quarter include plans to acquire OrthoGrid Systems, forming a partnership with CBRE Group for ASC growth and a partnership with RevelAiHealth.
3. Net earnings in the second quarter were $242.8 million, compared to $209.6 million in the same period last year.
4. Knee sales were $801.1 million, a 3.9% year-over-year increase, and hip sales grew 0.4% with $506.5 million in sales.
5. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were $469.5 million, a 6.1% increase year-over-year.
6. Zimmer Biomet lowered its full-year guidance and now expects 2024 revenue to grow 4% to 5%. Previously that growth was projected at 4.5% to 5.5%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
